Although CD11b expression was not verified in the in vivo study to focus on the M1 TAM phenotype, the evaluation of other immune cells differentiated from myeloid cells would be helpful to determine the direct or indirect reciprocal effects of TAMs and other immune cells in colon cancer. This evidence concerns the gene ITGAM and malignant colon neoplasm.